This trial is testing a treatment for high-risk prostate cancer using high-energy X-rays to target and kill cancer cells in the prostate and pelvic area. Some patients may also receive hormone therapy to lower testosterone levels, which can help slow cancer growth. The goal is to see if this combined approach is effective for patients who are at a higher risk of their cancer spreading or not responding to standard treatments.